The first step in the action of polypeptide hormones appears to be rapid, reversible interaction between hormone in the extracellular medium and specific recognition sites on the plasma membrane of target cells (1) (2) (3) . In previous studies (3), using [1251 ]ACTH, we have demonstrated directly the binding of ACTH to its biologically important receptors. Others have studied binding of [125I] angiotensin to several tissues (4) and of radioiodinated glucagon to the plasma membrane fraction from rat liver (5, 6) .
The binding of radioactively labeled insulin to tissues has been measured in many studies, including one reported recently (7) in which binding to the plasma membrane fraction from rat liver was studied, but uncertainties about the bioactivity of the iodinated molecules, the site of the binding, and proportion of "nonspecific" binding have limited the scope of the conclusions (8) (9) (10) (11) (12) (13) (14) (15) . We developed a method for the preparation of monoiodoinsulin that is as active as uniodinated insulin in stimulating glucose oxidation in isolated fat cells (16, 17) .
[125I]insulin so prepared was bound to isolated fat cells and to purified liver membranes (16, 17) . We describe here the biological specificity and other characteristics of [125I linsulin binding to its receptors in the liver.
MATERIALS AND METHODS Insulins and other hormones
Human (258-1025B-88), bovine (795372), and porcine (PJ 5589) insulins, porcine proinsulin (615-984B-99-C), and * Permanent address: Groupe U.55 (I.N.S.E.R.M.), Hotel-Dieu, 1 The tip of the plastic microtube, which contained the pellet, was excised and counted.
Trypsin treatment of liver membranes
To study the effect of trypsin on the insulin receptor in liver membranes, we added trypsin (Type III, Sigma) at 0.02 mg/ ml to membranes, 2 mg of membrane protein per ml, in 1 mM KHCO3, pH 7.8. After 30 min at 300C, soybean trypsin inhibitor (Type I., Sigma) was added at 0.2 mg/ml. These membranes were then used immediately for binding of [125ILin-sulin. In the control for this experiment, the membranes were treated identically except that trypsin inhibitor was added before rather than after the 30-min incubation with trypsin.
RESULTS 1l25linsulin binding to liver membranes
When [(251]insulin at 0.7 nM was incubated with purified liver membranes, about 25%o of the radioactivity was bound to the membranes ( From the data in Figs. 2 and 3 , we compared the potency of each insulin and insulin derivative in each system to the potency of porcine insulin. The numbers in the table = molar concentration of porcine insulin to achieve 50% effect molar concentration of peptide to achieve 50% effect When the response curve for an insulin or insulin derivative was not parallel to that of porcine insulin, the range of relative potency is indicated in parentheses.
* These preparations were not assayed in fat cells; the biological activity reported by the supplier was used to determine their potencies relative to that of porcine insulin.
human and bovine insulin, which differ from porcine in one and two amino acids, respectively (25) , but have identical biological potencies, were indistinguishable in their ability to inhibit porcine [1251I Jinsulin binding to rat liver membranes (Fig. 1) .
The ability of insulins and insulin derivatives to inhibit [1251 linsulin biilding to liver membranes was in all cases directly correlated with (Fig. 2) , and almost exactly proportional to (Table 1) , their capacity to stimulate glucose oxidation in isolated fat cells. For example, by comparing the concentrations needed to achieve half of the maximum effect, we found that a fish (bonito) insulin preparation that differs from porcine insulin in at least 10 amino acids and lacks residue B3o (25) (26) , and for carboxypeptidasetreated and trypsin-treated bovine insulins, which lack two and eight amino acids, respectively (27) , as well as for guineapig insulin, which has 17 amino-acid substitutions relative to pork insulin (25) . The A and B chains of porcine insulin, with blocked SH groups, alone and in combination, had (Fig. 2) less than 1/5000th of the ability of insulin both to inhibit [125I]_ insulin binding to liver membranes and to stimulate glucose oxidation in fat cells. ACTH, growth hormone, and glucagon were also without significant effect (Fig. 1) .
Radioimmunoassay By contrast, it is known that the insulin radioimmunoassay often discerns differences in insulin structure that are almost unrelated to the biological activity of the molecule (20, 28) . Using an anti-porcine insulin serum, we, like others (20, 28) , have found (Fig. 3, Table 1 ) that human, bovine, and even more strikingly, fish and guinea pig insulins had immunoreactivities that were clearly low as compared to their relative biological activities, whereas porcine proinsulin and the two enzyme-treated bovine insulins had immunoreactivities that clearly exceeded their relative biological potencies. As in the two biological systems, separated chains were almost inert immunologically; the activities observed were compatible with minute contamination (<0.02%/) with intact insulin (Fig. 3) . Incubation for 90 min longer resulted in no further change in the binding (Fig. 4) . The degree of binding was temperaturedependent: at 0WC, binding was about half that at 30'C (Fig. 4) . Decreased affinity at lower temperatures is also observed for binding of ACTH to adrenal (29) and glucagon to liver (6) . At 300C, addition of an excess of unlabeled insulin (10 uM) resulted in dissociation of 40% of the bound [1251]_ insulin within 10 min (Fig. 4) 15 1.0 880
[121I]insulin at 1.1 nM (6.6 ng/ml) was incubated with cellular fractions at the concentrations indicated, in the absence and presence of unlabeled insulin at 2 LM. Table 2 ). Treatment of the purified membranes with trypsin (see Methods), a procedure that abolishes the insulin response of fat cells (30) , and insulin uptake from the medium by fat cells (31) and by subcellular fractions of fat cells (32) , reduced the binding of [125I]insulin from 16 to 1%.
DISCUSSION
The data presented here strongly suggest that the labeled insulin is binding to its specific biologically important receptors, and that "nonspecific" binding is trivial. In the presence of high concentration of albumin, a minute volume of membranes bound 25% of the [1251 ] insulin to which it was exposed. The insulin concentrations for binding and displacement were in the range of hepatic portal blood concentrations in vivo (33 The percentage of total radioactivity in the membrane pellet is plotted as a function of time after the addition of unlabeled insulin.
of the hormone-receptor complex in activating cellular processes. There is evidence with other peptide hormones that in fact these two functions are structurally separate (34) (35) (36) (37) . The inhibition of binding of the labeled hormone reflects only the affinity of hormone for receptor. Since the bioactivity in all cases paralleled inhibition of binding, we concluded that differences in bioactivity among the insulin preparations studied can be ascribed entirely to differences in binding affinity. Likewise, our data suggest that proinsulin has reduced affinity for receptor but that the proinsulin-receptor complex has full capacity to activate cellular processes. Although binding affinities of the hormone to receptor and efficiency of the hormone-receptor complex in activating cells can vary independently, thus far no insulins have been reported in which dissociation of these functions has been detected with certainty. With the availability of the complete x-ray structure of insulin (38) , the binding system provides an excellent tool by which the structural requirements of hormone for binding to receptor can be studied directly.
The insulin radioimmunoassay discriminates well the amino acid substitutions that are characteristic for each species but discriminates poorly changes in structure that affect biological function (20, 28 
